Objective
To investigate the expression of platelet-derived endothelial growth factor (PDGF) and its effect in angiogenesis in endometrial
cancer (EC), in order to investigate the mechanism of tumorigenesis and lay a foundation for the management of EC.
Methods
We selected 40 cases with EC, 20 endometrium, and 20 normal endometrium. All specimens were stained immunohistochemically
for CD34 and PDGF identified immunohistochemically with specific antibodies.
Results
The expression of PDGF was significantly higher in EC than normal endometrium and atypical hyperplasia of endometrium (P < 0.05), however, no significant difference was found between normal endometrium and atypical hyperplasia of endometrium
(P > 0.05). The expression of PDGF was lower in well differentiated than moderately and poorly differentiated EC (P < 0.05). In cases with muscular invasion tumors, it was higher than in normal endometrium (P < 0.05). After Spearman correlation analysis, MVD was significantly influenced by PDGF, r = 0.848 (P = 0.000).
Conclusion
There was positive correlation between microvessel density (MVD) and PDGF in earlier stage of EC, it illustrate that PDGF
may take part in angiogenesis of EC.
Key words endometrial cancer (EC) - immunohistochemistry - microvessel density (MVD) - platelet-derived endothelial growth factor (PDGF)